4th Quarter - Report
PURDUE PHARMA, LP for PURDUE PHARMA LP
Firm
Client
Income
—
Expenses
$170,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
-Abuse Deterrent Formulation Issues -Patent Settlements
| Lobbyist | Covered position, as disclosed |
|---|---|
| BURT E ROSEN | — |
Health Issues HCR
-Disposal of Unused Medicines -Harmonization of abuse deterrent formulations between US FDA & Health Canada -Hearings related to prescription drug abuse and prevention -Abuse Deterrent Formulation Issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| BURT E ROSEN | — |
Alcohol and Drug Abuse ALC
-Disposal of Unused Medicines -Harmonization of abuse deterrent formulations between US FDA & Health Canada -Hearings related to prescription drug abuse and prevention -Abuse Deterrent Formulation Issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| BURT E ROSEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.